CARDIOFLOW-B: PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION
CARDIOFLOW-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
CARDIOFLOW-B: ESTIMATED ANNUAL RESULTS FOR THE YEAR 2023 AND BUSINESS UPDATE
CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
CARDIOFLOW-B: VOLUNTARY ANNOUNCEMENT - NMPA APPROVAL FOR REGISTRATION APPLICATION OF ANCHORMAN LAAC SYSTEM
CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
CARDIOFLOW-B: CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 51% EQUITY INTEREST IN MP CARDIOADVENT AND CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
CARDIOFLOW-B: POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 29, 2023
CARDIOFLOW-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
CARDIOFLOW-B: NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS
CARDIOFLOW-B: FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, DECEMBER 29, 2023
CARDIOFLOW-B: NOTICE OF EXTRAORDINARY GENERAL MEETING
CARDIOFLOW-B: (1) RENEWAL OF EXISTING CONTINUING CONNECTED TRANSACTIONS (2) CONTINUING CONNECTED TRANSACTION IN RELATION TO 2023 DISTRIBUTION FRAMEWORK AGREEMENT AND (3) NOTICE OF EXTRAORDINARY GENERAL MEETING
CARDIOFLOW-B: (1) RENEWAL OF EXISTING CONTINUING CONNECTED TRANSACTIONS (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO 2023 DISTRIBUTION FRAMEWORK AGREEMENT AND (3) CLOSURE OF REGISTER OF MEMBERS
CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
CARDIOFLOW-B: VOLUNTARY ANNOUNCEMENT - PROPOSED PURCHASE OF SHARES UNDER THE SHARE AWARD SCHEME
CARDIOFLOW-B: VOLUNTARY ANNOUNCEMENT - VITAFLOW LIBERTY COMPLETED SEVERAL PRE-MARKET CLINICAL IMPLANTATION CASES IN EUROPE
No Data